奥泰生物: 第三届董事会第十四次会议决议公告

Group 1 - The board of directors of Hangzhou Aotai Biotechnology Co., Ltd. held its 14th meeting of the third session on August 8, 2025, to discuss and vote on various proposals [1][2] - The board proposed to adjust the grant price of the 2022 Restricted Stock Incentive Plan from 25.0725 yuan per share to 23.5992 yuan per share, with a unanimous vote of 4 in favor [2][3] - The board approved the vesting of restricted stocks for 94 eligible incentive objects, totaling 409,472 shares, and for 18 reserved incentive objects, totaling 29,418 shares, based on the fulfillment of vesting conditions [2][3] Group 2 - The board decided to cancel 6,177 shares of restricted stock that were granted but not vested due to three incentive objects leaving the company [3][5] - All proposals discussed in the meeting were approved with no votes against or abstentions, indicating strong support from the board members [2][3]